Home Newsfeeds Indaptus Therapeutics Q3 EPS $(0.42) Up From $(0.81) YoY

Indaptus Therapeutics Q3 EPS $(0.42) Up From $(0.81) YoY

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.42) per share. This is a 48.15 percent increase over losses of $(0.81) per share from the same period last year.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.42) per share. This is a 48.15 percent increase over losses of $(0.81) per share from the same period last year.

Eliem Therapeutics Q2 EPS $(0.56) Up From $(3.11) YoY

By Benzinga Newsdesk

August 15, 6:12 AM

Eliem Therapeutics (NASDAQ:ELYM) reported quarterly losses of $(0.56) per share. This is a 81.99 percent increase over losses of $(3.11) per share from the same period last year.

ELYM

Neuronetics Announces Continued Momentum From Health Plans For TMS Therapy Coverage

By Benzinga Newsdesk

November 9, 9:38 AM

Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders,

STIM